• Publications and Articles Trending in Science and Technology

on: Last Friday
by: Futurism

OraMed's Strategic Pivot Following Oral Insulin Clinical Failure

35

OraMed Pharmaceuticals is pivoting its strategic investment direction following the clinical failure of its oral insulin drug candidate due to bioavailability challenges.